다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Alimentary pharmacology & therapeutics, v.18 no.6, 2003년, pp.587 - 594
Scholten, T. , Gatz, G. , Hole, U.
AI-Helper
SummaryAim: To compare the efficacy of pantoprazole and esomeprazole for the treatment of gastro-oesophageal reflux disease- (GERD-) related symptoms.Methods: In this multicentre, randomized, double-blind study 217 patients [intention-to-treat (ITT) population] diagnosed with end...
Revicki,, Crawley,, Zodet,, Levine,, Joelsson,. Complete resolution of heartburn symptoms and health‐related quality of life in patients with gastro‐oesophageal reflux disease. Alimentary pharmacology & therapeutics, vol.13, no.12, 1621-1630.
10.1001/archinte.152.4.717
Arch Intern Med Fennerty MB 477 156 1996 10.1001/archinte.1996.00440050019003 The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines
J Am Med Assoc Kahrilas PJ. 983 276 1996 10.1001/jama.1996.03540120061035 Gastroesophageal reflux disease
Dent, J, Jones, R, Kahrilas, P, Talley, N J. Management of gastro-oesophageal reflux disease in general practice.. BMJ : British medical journal, vol.322, no.7282, 344-347.
Kaplan-Machlis, Barbara, Spiegler, Gerard E, Revicki, Dennis A. Health-Related Quality of Life in Primary Care Patients with Gastroesophageal Reflux Disease. The Annals of pharmacotherapy, vol.33, no.10, 1032-1036.
Dimenäs, E., Carlsson, G., Glise, H., Israelsson, B., Wiklund, I.. Relevance of Norm Values as Part of the Documentation of Quality of Life Instruments for Use in Upper Gastrointestinal Disease. Scandinavian journal of gastroenterology, vol.31, no.suppl221, 8-13.
Glise, H., Hallerbäck, B., Johansson, B.. Quality of Life Assessments in the Evaluation of Gastroesophageal Reflux and Peptic Ulcer Disease before, during and after Treatment. Scandinavian journal of gastroenterology, vol.30, no.suppl208, 133-135.
J Am Med Assoc Stewart AL 907 262 1989 10.1001/jama.1989.03430070055030 Functional status and well‐being of patients with chronic conditions. Results from the Medical Outcomes Study
Knuuti, M.J., Wahl, M., Wiklund, I., Smith, P., Alhainen, L., Harkonen, R., Puska, P., Tzivoni, D.. Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina. The American journal of cardiology, vol.69, no.19, 1525-1532.
Nissinen, A., Wiklund, I., Lahti, T., Akkila, J., Wilson, A., Wahl, M., Puska, P.. Anti-anginal therapy and quality of life A comparison of the effects of transdermal nitroglycerin and long-acting oral nitrates. Journal of clinical epidemiology, vol.44, no.9, 989-997.
Dimenüs, E.. Methodological Aspects of Evaluation of Quality of Life in Upper Gastrointestinal Diseases. Scandinavian journal of gastroenterology, vol.28, no.suppl199, 18-21.
WareJEJr KosinskiM KellerSD.SF‐36 Health Survey. Manual and interpretation guide. Boston MA:The Health Institute New England Medical Center 1993.
10.1080/11024159850191238 WiklundIK JunghardO GraceE et al.quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease‐specific questionnaire (QOLRAD).Eur. J Surg. Suppl1998:41-9.
Colwell, Hilary H., Mathias, Susan D., Pasta, David J., Henning, James M., Hunt, Richard H.. Development of a Health-Related Quality-of-Life Questionnaire for Individuals with Gastroesophageal Reflux Disease (A Validation Study). Digestive diseases and sciences, vol.44, no.7, 1376-1383.
Gastroenterol Clin Biol Raymond JM 32 23 1999 [Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire]
Svedlund, Jan, Sj�din, Ingemar, Dotevall, Gerhard. GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive diseases and sciences, vol.33, no.2, 129-134.
JOHNSSON, F., ROTH, Y., PEDERSEN, N.‐E. DAMGAARD, JOELSSON, B.. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Alimentary pharmacology & therapeutics, vol.7, no.1, 81-86.
J Am Coll Surg Velanovich V 217 183 1996 Quality of life scale for gastroesophageal reflux disease
Am J Gastroenterol Schenk BE 1997 92 1997 Omeprazole as a diagnostic tool in gastroesophageal reflux disease
Rothman, Margaret, Farup, Christina, Stewart, Walter, Helbers, Lawrence, Zeldis, Jerome. Symptoms Associated with Gastroesophageal Reflux Disease. Digestive diseases and sciences, vol.46, no.7, 1540-1549.
10.1080/11024159850191355 JunghardO LauritsenK TalleyNJ WiklundIK.Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non‐ulcer dyspepsia.Eur. J Surg. Suppl1998:106-11.
Armstrong, D, Bennett, JR, Blum, AL, Dent, J, De Dombal, FT, Galmiche, JP, Lundell, L, Margulies, M, Richter, JE, Spechler, SJ, Tytgat, GN, Wallin, L. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology, vol.111, no.1, 85-92.
Gut (Suppl III) Koerner T A166 51 2002 Comparable efficacy of pantoprazole 40 mg vs. omeprazole MUPS 40 mg in patients with GERD II/III
van Rensburg, C. J., Bardhan, K. D.. No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology, vol.13, no.8, 909-914.
Bardhan, K.D.,. Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease. Drugs of today, vol.35, no.10, 773-.
Int J Clin Pract Thitiphuree S 537 54 2000 10.1111/j.1742-1241.2000.tb10919.x Esomeprazole, a new proton pump inhibitor. pharmacological characteristics and clinical efficacy
Kahrilas, P. J., Falk, G. W., Johnson, D. A., Schmitt, C., Collins, D. W., Whipple, J., D'Amico, D., Hamelin, B., Joelsson, B.. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Alimentary pharmacology & therapeutics, vol.14, no.10, 1249-1258.
Carlsson, Rolf, Dent, John, Watts, Richard, Riley, Stuart, Sheikh, Rajan, Hatlebakk, Jan, Haug, Kjell, de Groot, Gerrit, van Oudvorst, Arnold, Dalväg, Agneta, Junghard, Ola, Wiklund, Ingela. Gastro-oesophageal reflux disease in primary care : an international study of different treatment strategies with omeprazole. European journal of gastroenterology & hepatology, vol.10, no.2, 119-124.
Revicki, D A, Wood, M, Wiklund, I, Crawley, J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, vol.7, no.1, 75-83.
Festen, Henk P.M, Schenk, Ed, Tan, Gie, Snel, Pleun, Nelis, Frits. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.94, no.4, 931-936.
Acta Med Vcev A 79 53 1999 Pantoprazole versus omeprazole in the treatment of reflux esophagitis
Richter, Joel E., Kahrilas, Peter J., Johanson, John, Maton, Paul, Breiter, Jeffrey R., Hwang, Clara, Marino, Victoria, Hamelin, Bernard, Levine, Jeffrey G.. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.96, no.3, 656-665.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.